News (1)
Australia and WHO work together to strengthen SARS-CoV-2 testing in Mongolia
Publisher : WHO Representative Office in Mongolia
On April 9, Australia and the World Health Organization (WHO) signed a AUD 490,000 grant to assist the Government of Mongolia and WHO efforts in Mongolia to increase COVID-19 testing capacity. The funding will strengthen and expand PCR testing and diagnosis in Ulaanbaatar and key regional centers.
Signing on behalf of the Australian Government was HE Mr Dave Vosen, Australian Ambassador to Mongolia, while Dr Sergey Diorditsa, WHO Representative to Mongolia, signed on behalf of the WHO.
The “Surge capacity for early detection and active surveillance for COVID-19 in Mongolia” project will be managed by WHO Representative’s Office in Mongolia. In addition to increasing testing capacity, the project also aims to strengthen laboratory capacity in genomic sequencing of SARS-CoV-2. Australia’s contribution will help procure and mobilize additional testing supplies and reagents. This will increase the number of specimens available for testing.
Combined with Ministry of Health and WHO activities that continue to provide ongoing COVID-19 testing training for staff at national and regional laboratories, the funding will increase the number of tests enabling the detection of mild and asymptomatic cases in the early stages so potential complications due to COVID-19 can be prevented and detect variants of SARS-CoV-2 virus.
“Australia is a strong and active partner in Mongolia and is working hard to strengthen our region's economic recovery, its health security and its stability. This funding, in addition to our support for vaccine procurement and distribution is another tangible activity driven by Australia’s priorities under our Partnerships for Recovery strategy,” said Mr Dave Vosen.
“As part of these efforts, we are pleased to partner with the WHO Representative’s Office in Mongolia to help minimize the risk of local transmission of COVID-19 in Mongolia at this critical time.”
Thanking the Government of Australia for this very timely contribution to further strengthen the national laboratory capacity in Mongolia, Dr Sergey Diorditsa said, “In preparation for launching the project, WHO has provided support to train three laboratory technicians from the National Center for Communicable Diseases in genomic sequencing in Japan. The project will help Mongolia not only conduct testing and early detection, but will provide support to detect variants of the virus by enabling laboratories to do genomic sequencing.”
News (2) to (4) / Source : Montsame
News (2)
SARS-CoV-2 vaccine rollout paused for two weeks
The government of Mongolia has put the country under strict lockdown for 15 days between April 10 and April 25 with a view to curb the spread of the COVID-19 pandemic.
On April 9, the Ministry of Health reported that during this period, the nationwide vaccination drive will be paused and the vaccination sites will be closed amid the rising cases of coronavirus in Mongolia. The decision to halt the vaccine rollout, which kicked off on February 23, was made with a view to avoid the gathering of crowds at vaccination sites and breaking social distancing rules during the lockdown.
The decision causes a 15-day of delay in the second dose that was due from April 10 to those who had already received the first dose of the coronavirus vaccines. The Health Ministry assured that the recommended dates of administering second doses of the COVID-19 vaccines used in Mongolia, including Sinopharm, AstraZeneca, Sputnik-V and Pfizer-BioNTech, are from 21 days up to 12 weeks following the first dose and the delay does not impact the effectiveness of the vaccines.
The healthcare employees who were working for the vaccination will be mobilized for coronavirus detection and response and close contacts tracing measures.
Responding to public criticism for the decision and skepticism that the vaccine stocks may have run out, Deputy Prime Minister and Chair of the State Emergency Commission S.Amarsaikhan on April 10 informed that Mongolia has about 192,000 doses of coronavirus vaccines available in reserve. He further said that the shipments of a total of another 600,000 doses of vaccines against COVID-10, which were scheduled on April 9 and 12, have been postponed due to transportation issues.
According to Minister of Health S.Enkhbold, the vaccine rollout will be intensified from April 26 and all adult population in Ulaanbaatar city will be at least partially vaccinated within May 1 and will receive the second dose by May 31. The Health Minister also said that additional 120-160 vaccination sites will be set up during the 15 days of the ongoing lockdown to allow 60,000 people at a minimum to receive the vaccine each day as soon as the lockdown is lifted.
Although the vaccination is suspended for 15 days, Minister of Health Enkhbold confirmed that elderly people aged 60 years and older with chronic diseases will be immunized during the lockdown and mobile units will operate to vaccinate them in their homes if necessary.
Currently, Mongolia has received a total of 809,740 doses of COVID-19 vaccines, including 164,000 doses of AstraZeneca via India’s assistance and COVAX Facility, 600,000 doses of Sinopharm vaccine from China through donation and procurement, and 20,000 doses of Sputnik-V vaccine purchased from Russia and 25,740 doses of Pfizer-BioNTech vaccine via COVAX Facility.
As of April 10, a total of 609,875 adult people, or 29 percent of the nationwide vaccination target has already received the first dose of COVID-19 vaccines. 488,254 people of the vaccinated population are in the capital city and the remaining 121,621 people are in rural aimags.
News (3)
Mongolia reports 704 new covid cases on 12 April 2021
According to the Ministry of Health, 704 people were detected with coronavirus after performing tests on 13,591 people in 23 laboratories nationwide in the past 24 hours.
In specific, 598 were registered in over 150 khoroos of Ulaanbaatar city while 106 cases were reported in rural areas. No new imported cases of COVID-19 have been recorded.
Mongolia now has 15,718 confirmed cases of COVID-19. In the past 24 hours, 357 people have discharged from hospital, bringing the number of recoveries to 9,516. Today, 2,637 people are undergoing treatment, of whom 19 are in very critical health condition.
Newly confirmed cases of COVID-19 in rural areas in the past 24 hours: 7 new cases in Khovd, 8 in Darkhan-Uul, 16 in Orkhon, 3 in Arkhangai, 7 in Uvurkhangai, 28 in Tuv, 8 in Selenge, 1 in Dornod, 9 in Sukhbaatar, 3 in Khuvsgul, 1 in Zavkhan, 9 in Dundgobi and 6 in Bayankhongor aimag respectively.
News (4)
Mongolian elderly being vaccinated from 12 April 2021
The Ministry of Health, National Gerontology Center, Capital City Health Department, WHO Representative Office in Mongolia, and Mongolian Red Cross Society are collaborating to involve rural citizens, who are stranded in the capital city, and elderly people aged 60 years and older with chronic diseases and who are in home care in the vaccination against COVID-19.
Today, a permanent vaccination site has been opened in each district to get the target group of citizens inoculated. Specifically, vaccination is being conducted at School No. 113 in Bayanzurkh district, School No. 20 in Bayangol district, Health Center of Baganuur district, ‘Avragch’ Sports Committee of Chingeltei district, School No. 9 in Songinokhairkhan district, School No. 11 in Sukhbaatar district, Mongolian-Korean Polytechnic College in Khan-Uul district and Health Centers of Bagakhangai and Nalaikh district.
In addition, volunteers of the Mongolian Red Cross Society are working to carry the elders to the vaccination sites by three buses in each district.
News (5)
1 inbound passenger in Changzhou, Jiangsu has positive nucleic acid after being lifted from quarantine
Report by : Gan Yung Chyan, KUCINTA SETIA
According to the Changzhou Daily News, on April 11, 2021, the Changzhou Center for Disease Control and Prevention reported that during the routine nucleic acid test of people returning from entry from the quarantine, it was found that a person returning from Guangzhou's centralized quarantine period had a positive nucleic acid test. .
Zhang received a 14-day quarantine medical observation in the local area after entering from Guangzhou on March 26. He boarded Shenzhen Airlines flight ZH9675 to Changzhou Benniu Airport on the day the quarantine was lifted on April 9, and then took a taxi back to Lantian Garden community home. According to the latest national and provincial health management requirements for immigrants, they will undergo home health monitoring after they are released from quarantine. Routine nucleic acid tests will be carried out on April 11, and the result will be positive, that is, they will be transferred by a 120 negative pressure ambulance to a designated hospital for isolation treatment. After consultation with city-level experts, combined with clinical and imaging findings and laboratory nucleic acid test results, it was diagnosed as asymptomatic infection.
The Changzhou Headquarters has implemented isolation treatment and epidemiological investigation of Zhang as required, carried out investigation, tracking and management of relevant contacts, and adopted measures such as closed management and elimination of relevant places. As of 12 pm on April 12, all the close contacts found were quarantined for medical observation as required, and nucleic acid sampling and testing were completed. The nucleic acid test results were all negative.
Zhang's main activity tracks are as follows:
April 9:
Baiyun Airport-Benniu Airport (18:35-20:45, flight number: ZH9675);
Benniu Airport-Lantian Garden Community (21: 00-21: 39, taxi license plate number: Su D7638X).
April 10:
Yiweixuan Noodle House (6:35-7:10);
Yinsi Noodle House, North Gate of Lantian Garden Community (8:20-8:40);
Five-star Aoyue Non-staple Food Firm, Xinyihua Supermarket Baiyun Store Mobile Business Hall (8:40-9:10);
China Mobile Changzhou Branch Office (9:10-11:10, taxi license plate number: Su D5797X, Su D8587X);
Five-star Aoyue Non-staple Food Firm, Yinsi Noodle House (11:45-12:00);
Huayuan Xincun Laojiang Hardware and Building Materials Store (19:40-19:50).
April 11:
Take the designated vehicle and transfer to Xinyue nucleic acid testing site for sampling and testing (8:00-9:00);
Yiweixuan Noodle Shop, Laojiang Hardware and Building Materials Store, New Alliance Real Estate Agency (9:00-10:40);
Xinte Supermarket (10:40-11:00);
Yiweixuan Noodle House (12:00-12:30);
Reporter : Ma Shuaisha / Publisher : China Sciecne Network / http://news.sciencenet.cn/htmlnews/2021/4/455830.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
News (6)
Experts explain in detail the contraindications and instructions for vaccination: Most people suffering from rhinitis and pharyngitis can be vaccinated
In response to the contraindications and symptoms of the SARS-CoV-2 (covi, novel coronavirus) vaccination, who can be vaccinated, and whether the covi vaccine can be vaccinated at the same time as other vaccines, experts in the field of disease control in China joined the State Council on the 11th in explaining in details at the press conference held by the joint control mechanism.
News (7)
Vaccination is possible if the contraindication disappears
Regarding the contraindications of covi vaccination, the "SARS-CoV-2 Vaccination Technical Guidelines (First Edition)" issued by the National Health Commission of China recently mentioned five vaccination taboos: one is the active ingredient of the vaccine and any inactive ingredient People who are allergic to the substances used in the production process, or have allergies during previous vaccination of similar vaccines; second are those who have had severe allergic reactions to vaccines in the past, such as acute allergic reactions, angioedema, dyspnea, etc.; Controlled epilepsy and other serious neurological diseases, such as transverse myelitis, Guillain-Barre syndrome, demyelinating diseases, etc.; fourth, those who are feverish, or suffering from acute diseases, or acute episodes of chronic diseases, or not Controlled patients with severe chronic diseases; fifth are pregnant women.
In this regard, Wang Huaqing, chief expert of the China Centers for Disease Control and Prevention's immunization program, said that among the five conditions, except for allergies, the other conditions are temporary. If the contraindication status no longer exists, the vaccine can be vaccinated. For example, patients with acute diseases can be vaccinated after recovery. Fever patients can be vaccinated after the fever has subsided, and patients in the acute onset of chronic diseases can be vaccinated after the disease is controlled.
Regarding allergies, Wang Huaqing pointed out that if the vaccinators are confirmed to have acute allergic symptoms due to the new crown vaccine, the vaccinators cannot receive the second shot.
"For people with common and frequently-occurring diseases such as rhinitis and pharyngitis, most people can be vaccinated." Wang Huaqing said that immunosuppressive drugs will affect the effect of vaccination. For patients with arthritis and other diseases, if they are taking such drugs , Need to inform the doctor.
"In order to make vaccination more effective and safer, vaccinators should truthfully report health status, past medication history, vaccine allergies and other matters to the doctor at the vaccination site, and the doctor will make the judgment." Wang Huaqing emphasized.
News (8)
Anxiety and psychogenic reaction
In response to some young women experiencing headaches, nausea and other uncomfortable symptoms after vaccination, Wang Huaqing said that according to the current clinical trial results and the results of adverse reaction monitoring after the vaccine was launched, most of the systemic reactions are general reactions and do not require special treatment. If the condition worsens or the vaccinator thinks it is necessary, seek medical treatment in time.
"After monitoring, some individual vaccinators have a psychogenic reaction, which may have something to do with the tension or psychological anxiety before and after vaccination." He emphasized that the vaccinators do not need to be overly anxious and should take a relaxed attitude to vaccinate the new crown vaccine. This will greatly reduce the appearance of psychogenic reactions.
"Before and after vaccination, try to maintain a stable life and routine." He pointed out that although drinking has not been found to affect the effect of the vaccine, excessive drinking does affect the immune function.
News (9)
Can the covi vaccine vaccinate people at the same time as other vaccines?
Regarding the question of whether the vaccine can be vaccinated at the same time and how effective the vaccination is, Wang Huaqing said that this involves the issue of vaccine interval. In the past, two points were mainly considered, one is whether it is a live attenuated vaccine, and the other is whether the two vaccines contain the same antigen. ingredient. If it is a live attenuated vaccine, or contains the same antigen composition, a certain interval is required for vaccination.
Wang Huaqing pointed out that the HPV vaccine (Human Papilloma Virus Vaccine) is an inactivated vaccine. It is a virus-like particle vaccine composed of protein subunits. The new coronavirus vaccine is also an inactivated vaccine. In theory, simultaneous vaccination will not affect inoculation effect.
"The reason why it is proposed that other vaccines, including HPV vaccine, cannot be vaccinated at the same time in the process of vaccinating the new crown vaccine. The main reason is to consider the identification of adverse reactions." Wang Huaqing said, if you encounter a situation that requires rabies vaccine or tetanus vaccine, it is recommended not to consider the time interval, the rabies vaccine and tetanus vaccine can be given priority.
News (10)
What are the considerations for epidemic prevention and control after the covi vaccine? Gao Fu said this
Reporter : Hu Danping / Publisher : The Paper / http://news.sciencenet.cn/htmlnews/2021/4/455794.shtm , http://news.sciencenet.cn/htmlnews/2021/4/455782.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
On April 10, the 2021 National Vaccine and Health Conference was held in Chengdu, Sichuan. Gao Fu, Director of the China CDC, delivered a speech on "SARS-CoV-2 Vaccine Immunization Strategy and Practice" at the conference. Gao Fu put forward several thoughts on the immunization strategy and prevention and control policies of the new crown epidemic in the future.
Gao Fu put forward that the first issue to consider is the timing of opening up international travel, such as considering the risk of opening up before the vaccine for the elderly.
"Differentiated prevention and control policies for vaccinators," Gao Fu said. For example, consider whether they still wear masks or need nucleic acid testing?
Gao Fu also said that when the global epidemic turns into a long-term low-level epidemic, how should China's prevention and control goals and strategies be determined, as well as vaccine development and use strategies for virus variants.
"We should also consider ways to address the low protection rate of existing vaccines." Gao Fu said, such as optimizing vaccination procedures and sequential vaccination with different technical routes (Editor's note: alternate vaccination of several vaccines).
News (11)
Gao Fu: When developing classic traditional vaccines, don’t ignore the infinite possibilities of mRNA vaccines
"Everyone should pay attention to mRNA vaccines. It provides humans with infinite thinking." On April 10, Gao Fu, director of the Chinese Center for Disease Control and Prevention, called on the 2021 National Vaccine and Health Conference that mRNA technology is effective in infectious diseases, AIDS, and genetic diseases. , Rare diseases, and tumors will provide various opportunities. It is hoped that when developing classic traditional vaccines, the benefits that mRNA vaccines may bring to humans will be taken into consideration.
From April 10 to 11, the 2021 National Vaccine and Health Conference was held in Chengdu, Sichuan. Gao Fu delivered a speech report on "New Coronary Vaccine Immunization Strategy and Practice" at the conference.
Gao Fu said in the report that we must pay attention to mRNA vaccines. We cannot ignore mRNA vaccines just because there are already several covi vaccines in China. Innovative thinking is needed to create mRNA vaccines creatively.
The Paper (www.thepaper.cn) noted that the covi mRNA vaccines currently on the market globally are mainly from foreign R&D companies Pfizer-BioNTech and Modena. In contrast, domestically, my country has already approved the conditional listing or emergency use of new coronavirus vaccines from five manufacturing companies. Among them, three inactivated vaccines and one adenovirus vector vaccine were conditionally approved for marketing; in addition, one recombinant novel coronavirus vaccine (CHO cell) was approved for emergency use.
In June 2020, the covi mRNA vaccine jointly developed by Suzhou Aibo Biotechnology Co., Ltd., the Institute of Military Medicine of the Academy of Military Sciences and Yunnan Watson Biotechnology, officially passed the drug clinical trial approval of the National Medical Products Administration and entered the Phase I clinical study stage, becoming China’s first mRNA vaccine to enter the clinical stage.
News (12)
Norwegian research: AstraZeneca vaccine can cause extremely high levels of antibodies, leading to serious side effects of blood clots
Reporter : Hao Xiaoli / http://news.sciencenet.cn/htmlnews/2021/4/455811.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
On April 10, local time, the Norwegian Radio and Television Company (NRK) reported that the Norwegian study pointed out that there is a link between the AstraZeneca vaccine and blood clots, but researchers still do not know which substances in the vaccine can trigger this side effect. The researcher studied 5 Norwegian patients aged 32 to 54 who had abnormal thrombosis within 10 days after vaccination with AstraZeneca. At the same time, the platelet count was low, and 3 patients died.
The study was published in the "New England Journal of Medicine" on the 9th. The results of the study showed that what the 5 patients had in common was that the antibody levels of the complex of platelet factor 4 (PF4) and polyanion were very high. These types of antibodies can activate and cause low platelet counts. Researchers call it Vaccine Induction Immune Thrombocytopenia (VITT).
Ingvild Sørvoll, chief physician of the UNN research team in Tromsø, said, "This is a side effect of drugs, in which antibodies against heparin drugs are formed. However, these patients are not treated with heparin. . When we checked the literature, this antibody was never described after vaccination."
Madsen, the medical director of the Norwegian Medicines Agency, said that it is not yet known what triggers this side effect, so this study is very important and provides a basis for further research.
Madsen said the study will influence the decision of the Norwegian Institute of Public Health (FHI) whether to re-vaccinate AstraZeneca.
It is reported that Norway stopped vaccinating AstraZeneca's new vaccine in early March, and the Norwegian Institute of Public Health will announce on April 15 whether to accept AstraZeneca mRNA vaccine in the clinical stage.
News (13)
Wu Zunyou: SARS-CoV-2 vaccination rate needs to reach 70%, 80% to produce group protection
Reporter : Ma Shuaisha / Publisher : the Paper / http://news.sciencenet.cn/htmlnews/2021/4/455829.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
A press conference on the Joint Prevention and Control Mechanism of the State Council of China was held in Beijing on the 11th. Wu Zunyou, chief epidemiologist of the Chinese Center for Disease Control and Prevention, pointed out that the covi vaccine needs to vaccinate up to 70% and 80% of the population in order to produce a group protection effect. This is why countries around the world are vigorously promoting vaccination.
He said that from the World Health Organization's covid epidemic information update, it can be seen that in January and February this year, the global epidemic situation has declined for a period of time, and then the global epidemic situation has rebounded and rebounded, especially in India and Brazil. The epidemic situation in Chile has been on the rise from December last year to April this year: At the beginning of December last year, the number of daily reports was about 2,000, and by the beginning of April this year, the number of daily reports reached 8,000. Chile began to promote vaccination nationwide in February. By the beginning of April, the number of people who received at least one dose accounted for 25% of the total population, but this proportion did not reach the vaccination rate needed to control the epidemic.
Wu Zunyou explained that vaccination has two protective effects: Firstly, it is the protective effect on the vaccinated individuals. In the vaccine phase III clinical trial, the assessment is to protect the individual. The antibodies produced by each individual after being vaccinated can protect themselves. The second is the protective effect among the crowd. When the vaccinated individuals reach a certain proportion, they can form protection for the group, so this is called herd immunity.
He said that the critical value of the vaccination rate required by herd immunity for different infectious diseases is different. The stronger the infectivity, the higher the proportion of vaccination required, and the weaker the infectious disease, the lower the vaccination rate required. For example, in covid, the vaccine needs to vaccinate 70% and 80% of the population in order to produce group protection effects. If the vaccination rate reaches 10%, 20%, 30%, or even 40%, it can only protect the individual and cannot produce herd immunity. When a source of infection is introduced, an epidemic will occur. "This is why all countries around the world are fighting vigorously to promote vaccination, and they must catch up with the next epidemic peak in autumn and winter to achieve the coverage required for herd immunization."
News (14)
Individual vaccinators have psychogenic reactions. China CDC: No need for excessive anxiety
Publisher : China Science Network / http://news.sciencenet.cn/htmlnews/2021/4/455824.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
The State Council’s Joint Prevention and Control Mechanism held a press conference on the afternoon of the 11th. The chief expert of the China CDC’s immunization program said at the meeting that some people experienced psychogenic reactions after being vaccinated with the new crown vaccine. Tension or psychological anxiety before vaccination, during vaccination, and after vaccination have a certain relationship. You do not need to be overly anxious during the vaccination process.
At the meeting, a reporter asked that some college girls are particularly concerned about vaccination issues. For example, will the effect of HPV vaccination be affected after being vaccinated with the covi vaccine? There are also some girls who are more worried about their weaker physique and will experience dizziness, nausea, fever and other uncomfortable symptoms after vaccination.
Wang Huaqing pointed out that whether vaccines can vaccinate the population at the same time involves the issue of vaccine intervals. In the past, two points were considered mainly based on past experience: One is whether it is a live attenuated vaccine, and the other is whether the antigenic components of the vaccine are the same. If it is a live attenuated vaccine, or if the antigen composition is the same, the vaccination needs a certain interval. When it comes to the HPV vaccine, because it is an inactivated vaccine, the novel coronavirus vaccine is also an inactivated vaccine, and the HPV vaccine is a protein subunit vaccine. In theory, there is no impact on the effect between the two.
Why is it that during the process of vaccinating the new crown vaccine this time, it cannot be vaccinated with other vaccines, including HPV vaccine, under normal circumstances, Wang Huaqing said, mainly considering the identification of adverse reactions. Therefore, under normal circumstances, it is not recommended that the covi vaccine and HPV vaccine be vaccinated at the same time as there are other vaccines. However, if you have been bitten by a dog or have trauma, you should not consider the time interval when injecting rabies vaccine or tetanus vaccine. You can be given priority to rabies vaccine and tetanus vaccine.
As for some young women who have headaches, nausea and other symptoms after being vaccinated, Wang Huaqing said that according to the results of clinical trials and the results of adverse reaction monitoring after the vaccine is launched, most systemic reactions are general reactions. No special treatment is required. If the condition gets worse, or if it is deemed necessary, seek medical treatment in time.
Wang Huaqing emphasized that because the vaccinated population is mainly 18-59 years old, there are some women in it. According to the current surveillance, there are still a few individuals in this population who have a psychogenic reaction. Why do they have a psychogenic reaction? This may be related to stress or psychological anxiety before vaccination, during vaccination, or after vaccination. Certainly, this leads to psychogenic reactions.
So everyone thinks that it is an ordinary injection during the vaccination process, and there is no need to be overly anxious. It is necessary to vaccinate the vaccine with a relaxed attitude, which will greatly reduce the psychogenic reactions." Wang Huaqing said.
News (15)
National Health Commission responds to the “one size fits all” phenomenon of vaccination in some units
http://news.sciencenet.cn/htmlnews/2021/4/455825.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
The State Council’s Joint Prevention and Control Mechanism held a press conference on the afternoon of the 11th. Wu Liangyou, deputy director of the National Health Commission’s Disease Control Bureau, said at the meeting that certain areas are in the process of promoting new crown virus vaccination. , There are simplification problems. Although these problems are not universal, they also reflect that the organization and management of individual regions is not precise and precise enough.
At the meeting, it is reflected that some netizens left messages reflecting that some places and departments linked the vaccination status to the vital interests of employees, and some units even ignored the special physical conditions of some employees and required all employees to be vaccinated. In order to improve the vaccination rate of enterprises, how to treat this “one size fits all” phenomenon and what are the targeted measures?
Wu Liangyou said that at present, all localities are in accordance with the decisions and deployments of the Party Central Committee and the State Council, and in accordance with the principle of highlighting key points and ensuring safety, to do a good job in vaccinating against the novel coronavirus. Relevant provinces have adopted various effective measures based on local conditions. Gained some experience. However, there are simplification problems in the promotion of covi vaccination work in individual regions. Although these problems are not universal, they also reflect that the organization and management of individual regions is not precise and precise enough.
Wu Liangyou pointed out that in the next step, they will continue to strengthen the guidance to all regions, require all regions to improve the management and organization level of new crown virus vaccination, strengthen the training of vaccinators, rationally set up vaccination units, and organize the delivery of new crown virus vaccines in accordance with laws and regulations. Arrange the number of inoculations and the time of inoculation through precise appointments, effectively divert personnel, prevent personnel from gathering, and complete the entire process in accordance with the relevant specifications and requirements of vaccination.
He continued that the National Health Commission will continue to carry out targeted propaganda to guide the public to rationally view the abnormal and incidental reactions that may occur after vaccination, and to strengthen the people's confidence in domestic vaccines. Adults over the age of 18 are the subject of vaccination and are also a group with relatively frequent social activities. Vaccination is not only an effective protection for their own health, but also an effective protective barrier for the elderly and children at home. In the work, we will adhere to the principle of "receiving everything that should be met" and the principle of voluntariness, and on the basis of full notification, guide and encourage the masses to actively inoculate and actively inoculate, strive to achieve "receive all the time", and effectively improve the people's sense of gain, happiness, and security.
News (16)
Russian officials: Vaccines that can prevent influenza and COVID-19 at the same time are being tested on animals
Report by : Gan Yung Chyan, KUCINTA SETIA
According to the Russian Satellite Network, an official from the Research Center of the Russian Federation’s Consumer Rights Protection and Public Welfare Supervision Agency stated that the centre is currently conducting animal studies on a combined vaccine that can prevent both SARS-CoV-2 and influenza.
According to reports, Markshutov, director of the Russian "Vector" National Science Center for Virology and Biotechnology, said, "We are doing this kind of work. We are currently continuing to experiment on animals."
Makshutov further stated that this vaccine may have important epidemiological significance, because the vaccine will enable residents to prevent two infections at the same time each year when they are vaccinated, namely influenza and covid.
Ginzburg, Director of the National Research Center for Epidemiology and Microbiology in Russia, said in January that the "2 in 1" vaccine for influenza and covid may be available before the end of 2022. The Gamallea Center has developed such vaccines with preparation technology.
News (17)
How long is the protection period of the SARS-CoV-2 vaccine? What should I do if the virus has mutated? Authoritative response is coming
Reporters : Xu Penghang, Chen Xiyuan / Publisher : Xinhua News Agency / http://news.sciencenet.cn/htmlnews/2021/4/455770.shtm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
How long is the protection period of the SARS-CoV-2 vaccine? Is the protection period only half a year? What should I do if the new coronavirus has mutated? Experts from China's disease control experts responded: After six months of protection, there will still be a certain degree of effectiveness, and the vaccine will still have a certain degree of protection against existing mutant strains.
Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, said that the so-called half-year protection period only means that some people have low neutralizing antibodies after half a year. If they are infected by the virus, a large number of memory cells will be awakened to produce immunity. . "This is different from the immunity of people who have never been vaccinated."
Feng Zijian, deputy director and researcher of the Chinese Center for Disease Control and Prevention, said that at present, they have insufficient data on the protection period and durability of the vaccine. This is because it takes about half a year from the vaccine experiment to the market, which can be observed by us. The time is not long. "From the current data, the protection period of my country's marketed vaccines can be at least half a year. Will it be longer? This requires further observation."
In response to the mutant virus, Shao Yiming responded that the existing mutant strains can only partially reduce the protection efficiency of the vaccine. “The decline in protection efficiency that we have seen is generally for mild cases, and the protection efficiency for severe cases is relatively high.”
Shao Yiming introduced that after being vaccinated with the covi vaccine, the vaccinators will build a basic immunity to the novel coronavirus. If one day the virus mutates beyond the existing control range of the vaccine, the previous injections will not be in vain.
According to Yin Weidong, chairman of Beijing Kexing Zhongwei Biotechnology Co., Ltd., the company has initiated vaccine research on variant strains. Yin Weidong introduced that in the future, if the virus mutation accelerates to a certain degree, one possibility is to increase the antigen composition of a variant strain on the basis of the existing vaccine to become a bivalent vaccine; the other possibility is to inject two injections of the current vaccine. After that, another booster shot against the new mutant strain was injected.
"In the past year, my country's novel coronavirus vaccine research and development approval process has basically been straightened out. Compared with before, the research and development cycle for mutant strains will be shorter and the efficiency will be higher." Yin Weidong said.
Industry experts such as Shao Yiming urged that the current strain variation in the main epidemic areas of the global covid epidemic is still within controllable range, and large-scale vaccination should be carried out as soon as possible to build a stronger herd immune barrier, while also reducing the speed of virus mutation. Eventually contain the epidemic as soon as possible.
News (20) to (23) / Reporter : Zhong Yuan / Editor : Gao Yi / https://www.epochtimes.com/gb/21/4/11/n12873178.htm / Translation, editing : Gan Yung Chyan, KUCINTA SETIA
No comments:
Post a Comment